Treatment response, drug survival and safety of anti-tumour necrosis factor α therapy in 193 patients with psoriatic arthritis: A twelve-year “real life” experience - Archive ouverte HAL
Article Dans Une Revue Joint Bone Spine Année : 2015

Treatment response, drug survival and safety of anti-tumour necrosis factor α therapy in 193 patients with psoriatic arthritis: A twelve-year “real life” experience

Domaines

Sciences du Vivant [q-bio]

julien paccou  : Connectez-vous pour contacter le contributeur

https://hal.science/hal-04444985

Soumis le : mercredi 7 février 2024-17:26:35

Dernière modification le : mercredi 23 octobre 2024-09:32:20

Fichier non déposé

Dates et versions

hal-04444985 , version 1 (07-02-2024)

Identifiants

Citer

Anne-Sophie Soubrier, Peggy Bele-Philippe, Bernard Cortet, Nassima Ramdane-Sebbane, Marie-Astrid Bacle-Boutry, et al.. Treatment response, drug survival and safety of anti-tumour necrosis factor α therapy in 193 patients with psoriatic arthritis: A twelve-year “real life” experience. Joint Bone Spine, 2015, 82 (1), pp.31-37. ⟨10.1016/j.jbspin.2014.08.001⟩. ⟨hal-04444985⟩

Exporter

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

U938 UNIV-LILLE SORBONNE-UNIVERSITE SU-MEDECINE MABLAB
15 Consultations
0 Téléchargements

Altmetric

Partager

More